SCHEMBL9866653

SCHEMBL9866653

N=C(NCCCSc1ccccn1)NCCCc1c[nH]cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.39
RAB9A P51151 5/20 0.39
SMN1; SMN2 Q16637 5/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
HPGD P15428 1/20 0.39
ALDH1A1 P00352 6/20 0.39
TP53 P04637 1/20 0.37
LMNA P02545 3/20 0.36
KMT2A Q03164 4/20 0.36
MAPT P10636 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
MEN1 O00255 2/20 0.34
PKM P14618 2/20 0.34
USP2 O75604 1/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33
POLB P06746 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9865982 0.95 NPC1 (0.44) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9867497 0.86 KMT2A (0.38) NPC1RAB9ASMN1; SMN2HPGDALDH1A1
SCHEMBL7180733 0.82 LMNA (0.37) SMN1; SMN2ALDH1A1LMNAKMT2AMEN1
SCHEMBL9866660 0.82 NPY1R (0.37)
SCHEMBL9865147 0.81 MTNR1A (0.41) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9865989 0.81 EBP (0.38) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
Gapromidine SCHEMBL1818477 0.81 CYP1A2 (0.44) RAB9ASMN1; SMN2HPGDALDH1A1KMT2A
SCHEMBL9867195 0.80 HPGD (0.39) NPC1RAB9AHPGDALDH1A1LMNA
SCHEMBL9866274 0.80 TEAD1 (0.38) ALDH1A1TP53LMNAKMT2AMAPT
SCHEMBL9867117 0.79 L3MBTL1 (0.43) NPC1RAB9AHPGDKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed